Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 2/17/15  and contains information from public web pages and contributions from the ZoomInfo community.

Prof. Ted Maddess

Wrong Prof. Ted Maddess?

Centre Director

Phone: +61 *********  
Email: t***@***.au
Local Address:  ANU , Australia
The ARC Centre of Excellence in Vision Science
8 Ewart St
Malvern , Victoria 3144

Company Description: The ARC Centre of Excellence in Vision Science (ACEVS) brings together major research programs at the ANU with cognate programs at the Universities of Queensland,...   more

Employment History

Board Memberships and Affiliations

66 Total References
Web References
Governing Council and Committees, 17 Feb 2015 [cached]
Professor Ted Maddess Bsc PhD
Prof Maddess' original areas of interest were the optics of eyes and the adaptive neurophysiology of vision. Following several years working on animal models he ventured into the area of visual psychophysics and glaucoma resulting in the commercialisation of the FDT/Matrix perimeters for which he received the Clunies Ross Science and Technology Award in 2002. That work commenced a period of involvement with commercialisation and biotechnology. This included being the Head of the Biotechnology Transfer Unit (1999 to 2011) of his former ANU institute, the Research School of Biology; and Board member (2001 to 2004) of the Australian Centre for Intellectual Property in Agriculture (ACIPA). He was also on the Board of the ACT chapter of Biotech Australia and represented the ANU and the ACT government at the international BIO industry meetings (2001 to 2004). Prof Maddess has been a consultant to government (DSTO, DEST) and industry (Welsh Allen, Seeing Machines, EyeCo).
On the Academic side Prof Maddess has been a principle organiser of 22 national and international vision related conferences and symposia since 2000. He has been on the Editorial Board of Clinical and Experimental Ophthalmology since 2001. He became a member of the NHMRC Academy of Assigners in 2012. Since 2003 Prof Maddess has been chief investigator on grants worth $22 million. His research interests include adaptation to image motion, eye movements, illusions of brightness and scale, and for the last decade, discrimination of complex textures. An abiding interest has been the design of multifocal methods for functional assessment of the visual fields. Most recently this has translated into multifocal pupillographic objective perimetry (mfPOP), which he is developing with his colleague Dr Andrew James and Seeing Machines Ltd. They are currently attempting to improve mfPOP for use in diabetic retinopathy, macular degeneration, and glaucoma. He was elected for two 2-year terms (2007-2011) as Head of the ANU Centre for Visual Sciences. Since 2010 he has been Director of the ARC Centre of Excellence in Vision Science, a consortium of researchers at the ANU, U Melb, UQ, U Sydney, and UWA. Prof Maddess joined the NVRI Board of Administration in 2011. This e-mail address is being protected from spambots.
Research Staff | ARC Centre of Excellence in Vision Science, 15 Jan 2015 [cached]
Professor Ted Maddess (Centre Director) The Australian National University
ARC Centre of Excellence in Vision Science - Careers, 4 Sept 2011 [cached]
Laboratory Head: Prof. Ted Maddess,
"Our instrument uses special patterns of ..., 11 Jan 2014 [cached]
"Our instrument uses special patterns of flashing lights that the patient looks at for four minutes," says Professor Ted Maddess, a vision scientist at ANU who is head of the ACEVS team.
"MS is the most common neurological disability in adults, with about 12,000 sufferers in Australia," says Professor Maddess. "Although it seems to be some sort of immune disorder, its cause is still obscure.
"There are many puzzling aspects to MS, and there are many theories," he says.
The device was developed by Professor Maddess together with Associate Professor Andrew James and other ACEVS team members.
TrueField has already received American FDA clearance, and Professor Maddess is hopeful it might, after some more research, also find a role in monitoring MS. He believes it has good prospects of reducing the high treatment costs associated with the disease.
ANU - Eccles Institute of Neuroscience (EIN), 8 Feb 2013 [cached]
Ted Maddess
Other People with the name "Maddess":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.